Myron I. Murdock, MD, LLC

Greenbelt, Maryland 20770

0 studies enrolling now · 8 studies all time

What they study most

Advanced Prostate Cancer, Benign Prostatic Hypertrophy, Bladder Neoplasm, Carcinoma in Situ, Metastatic Androgen Independent Prostate Cancer, Mycobacterium, Neoplasm Recurrence, Local, Overactive Bladder, Prostate Cancer, Prostatic Neoplasms, Transitional Cell, Carcinoma

Studies at this site

• Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442) — Completed
• A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer — Completed
• Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH) — Stopped early
• Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer — Stopped early
• Open Label Study of Sipuleucel-T in Metastatic Prostate Cancer — Completed
• Study of AOBO-001 for Overactive Bladder With Urge Urinary Incontinence and Frequency — Completed
• Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH) — Completed
• Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy — Completed